病毒学
中国
人类免疫缺陷病毒(HIV)
慢病毒
西达
和男人发生性关系的男人
生物
病毒性疾病
医学
地理
梅毒
考古
作者
Hualu Cui,Wenqing Geng,Hong Sun,Xiaoxu Han,Minghui An,Yongjun Jiang,Zining Zhang,Zhiwei Chen,Junjie Xu,Qinghai Hu,Bin Zhao,Bennan Zhou,Hong Shang
出处
期刊:AIDS
[Ovid Technologies (Wolters Kluwer)]
日期:2018-08-12
卷期号:33 (1): 13-22
被引量:21
标识
DOI:10.1097/qad.0000000000001981
摘要
CRF01_AE is the most prevalent HIV-1 subtype among MSM in China. However, the characteristics and underlying mechanism of the accelerated CD4 T-cell decline in CRF01_AE-infected MSM remain incompletely understood.A long-term prospective follow-up study was conducted with 1388 MSM at risk of HIV-1 infection in Northeast China. MSM with primary HIV-1 CRF01_AE infection were identified and followed for 3-6 years to explore the determinants of rapid CD4 T-cell decline.Tropism was determined in primary infection by both single genome amplification-based genotypic prediction using four different algorithms and phenotypic determination using clinical isolates. Serial isolates were used to determine phenotype of coreceptor switch. Human leukocyte antigen genotypes and T-cell activation markers were determined.Fifty-nine MSM primarily infected with HIV-1 CRF01_AE were discovered and recruited for the follow-up study. CCR5-utilizing (R5) viruses accounted for up to 98% of HIV-1 CRF01_AE infections in Northeast China. Survival analysis indicated 39.5% of the patients underwent coreceptor switch within 3 years after infection. After adjustment for other potential risk factors, linear mixed-effect models demonstrated patients experienced R5 to CXCR4-utilizing/dual-tropic (X4/DM) coreceptor switch within 3 years after infection underwent a faster CD4 T-cell decline compared to those without coreceptor switch.Primary HIV-1 CRF01_AE infection among MSM in Northeast China is characterized by R5 viral infection and early R5 to X4/DM coreceptor switch, which is associated with rapid CD4 T-cell decline. The findings highlight the importance of immediate treatment among the CRF01_AE-infected MSM.
科研通智能强力驱动
Strongly Powered by AbleSci AI